Latest Debt Repayment News

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Explorers led the Materials tape as fresh drill stories and new ground deals pulled buyers into small caps. Big miners still delivered, but the loudest moves came from companies offering investors a near-term catalyst.

AVITA Medical reported an 11% increase in sales revenue for 2025, driven by deeper market penetration and new product launches, while reducing its net loss by 21%. The company secured a $60 million senior secured credit facility but flagged substantial doubt about its ability to continue as a going concern.

Evolution Mining has reported a record half-year profit, with statutory net income more than doubling to $766.6 million, driven by higher gold and copper prices. The company also declared a fully franked interim dividend of 20 cents per share and progressed key mine expansions and developments.

Elanor Investors Group has secured securityholder approval for a $125 million recapitalisation with Rockworth Capital Partners and the acquisition of Firmus Capital, marking a pivotal step in stabilising its balance sheet and positioning for growth.

Eagle Mountain Mining has reached a key milestone as Nittetsu completes due diligence on the Oracle Ridge copper project, moving closer to signing a joint venture agreement expected in April 2026.

Native Mineral Resources has made early repayments totalling nearly $2 million on its Collins St finance facility, reducing its debt well ahead of schedule. This move underscores the company's robust cash flow and strategic focus on its Charters Towers gold projects.

A single exploration name blew the doors off the leaderboard, while two well-known uranium plays and a Nevada explorer sank hard. Behind the noise: deals got closer to completion, big raisings reset prices, and several “good news” gaps didn’t survive the week.

Garda Property Group has upgraded its FY26 earnings guidance by 10%, reduced gearing to 20.8%, and outlined ambitious plans to expand its Brisbane industrial portfolio and lending operations.

Peak Processing Limited has completed a strategic rebrand and organisational restructure, securing new long-term manufacturing agreements and expanding product listings to strengthen its foothold in North America's regulated cannabis beverage markets.

TradeWindow Holdings Limited has launched a NZ$1 million Share Purchase Plan (SPP) offering eligible New Zealand and Australian shareholders the chance to buy shares at NZ$0.25 each, a 7% discount to recent trading prices. The capital raised will support the development of its Freight AI platform, debt reduction, and market expansion.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.